An 8-part, online event that's happening live. And it's all free.



Introducing the PodCase

CiDA is committed to holding our annual meeting in 2020. It will take the form of an online, one hour PodCase - delivered weekly for 8 weeks that remain controversial, fun, engaging, relevant and worth your time.


Access will be free, and the PodCases will be archived for later viewing.


CiDA 2020: Dates | Times | Topics Announced Soon!

CiDA will be announcing details in July. PodCases will begin October 2020. Pre-register to stay updated. 


A Bit About CiDA

The CiDA meeting was started 17 years ago by Ingemar Davidson MD, PhD, (a transplant surgeon) and Bart Dolmatch MD, FSIR, (an interventional radiologist) who saw a need to deliver better care for patients with kidney failure. Since its inception, the CiDA meeting has grown in popularity and continues to evolve with the changing times.


Bob Dylan put it best, the times they are a-changin'. And we are quickly adapting to these ever changing times by going virtual in 2020. 

The culture of this meeting is in its name - CiDA - the acronym for Controversies in Dialysis Access.

The kidney failure patient has complex medical needs, and optimal solutions to provide life-saving renal replacement may not be obvious. Surgeons, Nephrologists, Interventional Radiologists, staff at dialysis units, and others are all equipped with different training, experience, and expertise. All of these providers offer certain elements of patient care. But care isn’t seamless, and there are many different ways to “see” the issues that these patients face.

CiDA says, “Perfect. Bring your ideas and let’s see where we agree and disagree so we can improve care for people with kidney failure.”


The Controversies in Dialysis Access (CiDA) meeting is the leading educational forum for surgeons, radiologists, nephrologists and medical staff who care for dialysis access patients. We embrace controversy, reject bias and invite input from faculty and attendees alike…This is what sets CiDA apart.


Copyright © 2020 Dialysis Controversies Inc. All rights reserved. 



  • Twitter
  • LinkedIn